Engineered catfish and uses thereof

US12507679B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12507679-B2
Application numberUS-202217723159-A
CountryUS
Kind codeB2
Filing dateApr 18, 2022
Priority dateApr 16, 2021
Publication dateDec 30, 2025
Grant dateDec 30, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Descried in certain example embodiments herein are engineered fish, particularly engineered catfish, that are engineered to contain modified myostatin, melanocortin-4 receptor, and/or one or more n-3 fatty acid biosynthesis pathway genes and/or gene products.

First claim

Opening claim text (preview).

What is claimed is: 1 . An engineered fish of the genus Ictalurus whose genome comprises: a modified melanocortin-4 receptor gene or gene product, wherein the modified melanocortin-4 receptor gene or gene product has decreased or eliminated expression, activity, or both as compared to a suitable control; and an exogenous elongase gene, wherein the engineered fish of the genus Ictalurus has increased body weight, as compared to an engineered fish of the genus Ictalurus having only the modified melanocortin-4 receptor gene or gene product, and wherein the exogenous elongase gene is inserted into the melanocortin-4 receptor gene such that at least a portion of exon 1 or the entirety of the melanocortin-4 receptor gene is replaced with the exogenous elongase gene. 2 . The engineered fish of claim 1 , further comprising a modified myostatin gene or gene product, wherein the modified myostatin gene or gene product has decreased or eliminated expression, activity, or both as compared to the suitable control. 3 . The engineered fish of claim 1 , wherein the engineered fish has increased body weight, increased body mass, increased growth rate, increased amount of n-3 fatty acids, sterility, or any combination thereof as compared to a suitable control. 4 . The engineered fish of claim 1 , wherein the modified melanocortin-4 receptor gene or gene product expression, activity, or both are each decreased 2-1000 fold. 5 . The engineered fish of claim 2 , wherein the modified melanocortin-4 receptor gene or gene product expression, activity, or both are each independently decreased 2-1000 fold, wherein the myostatin gene or gene product expression, activity, or both, are each independently decreased 2-1000 fold, or both. 6 . The engineered fish of claim 2 , wherein a second exogenous gene is inserted into the myostatin gene such that at least a portion of or the entirety of the myostatin gene is replaced with the exogenous gene to generate the modified myostatin gene. 7 . The engineered fish of claim 6 , wherein the engineered fish has increased amount of docosahexaenoic acid in one or more cells or tissues, increased amount of eicosapentaenoic acid in one or more cells or tissues, increased disease resistance, or any combination thereof as compared to a suitable control. 8 . The engineered fish of claim 2 , wherein the engineered fish has increased body mass, increased growth rate, increased amount of docosahexaenoic acid in one or more cells or tissues, increased amount of eicosapentaenoic acid in one or more cells or tissues, increased disease resistance, or any combination thereof as compared to a suitable control. 9 . The engineered fish of claim 1 , wherein the engineered fish has increased body mass, increased growth rate, increased amount of docosahexaenoic acid in one or more cells or tissues, increased amount of eicosapentaenoic acid in one or more cells or tissues, or any combination thereof as compared to a suitable control. 10 . The engineered fish of claim 1 , wherein the engineered fish is I. punctatus, I. furcatus , or is a hybrid thereof. 11 . The engineered fish of claim 1 , wherein the modified melanocortin-4 receptor A gene or gene product is produced using a programmable nuclease system. 12 . The engineered fish of claim 11 , wherein the programmable nuclease system is a CRISPR-Cas system, a TALEN system, a Zinc Finger Nuclease system, or an IscB system. 13 . A feed or food product comprising: an engineered fish or portion thereof, wherein the engineered fish is an engineered fish according to claim 1 .

Assignees

Inventors

Classifications

  • from fish · CPC title

  • inducing loss of function · CPC title

  • Fish · CPC title

  • involving nucleic acids · CPC title

  • G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12507679B2 cover?
Descried in certain example embodiments herein are engineered fish, particularly engineered catfish, that are engineered to contain modified myostatin, melanocortin-4 receptor, and/or one or more n-3 fatty acid biosynthesis pathway genes and/or gene products.
Who is the assignee on this patent?
Univ Auburn
What technology area does this patent fall under?
Primary CPC classification A01K67/0276. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).